Health Care
Blog
MyTurn Is Actually a Marginal Success Compared to Historic Performance of Government Technology Projects
Reports this week have put MyTurn, California’s $50 million COVID-19 scheduling website, on the long list of IT and technology blunders by government. The headline in the Sacramento Bee says it all, “California spent $50 million for a COVID vaccine scheduling website. It flopped.” The state’s ongoing technological woes should ...
Commentary
With HR 3, House Democrats Lose Their Grip on Reality
Last week, House Democrats introduced H.R. 3, a bill that would empower the federal government to set prescription drug prices for the entire U.S. pharmaceutical market. The measure comes at the worst possible time. The rapid development of effective vaccines against COVID-19 has demonstrated what can happen when the drug industry ...
Commentary
Medicare for All Would Put Even More Strain on Doctors
Medicare for All is back on Congress‘s agenda. More than 100 House Democrats, led by Reps. Pramila Jayapal of Washington and Debbie Dingell of Michigan, are behind a bill that would outlaw private insurance and enroll every American in a government-run health plan within two years. They’re joined by a surprisingly large share of ...
California
Dr. Henry Miller – A COVID-19 Update and Progress on Vaccinations
This week’s guest is Dr. Henry Miller, PRI senior fellow in health care studies. In addition to being a physician, Dr. Miller was a former official at the FDA and founding director of the FDA’s Office of Biotechnology. Dr. Miller provides an update on the pandemic, the progress of vaccine ...
Commentary
Europe Negotiates A Poor Vaccine Rollout
Several European countries just instituted another round of lockdowns amid a new wave of Covid-19 cases. This turn of events is sobering but puzzling. Europe seemed to have Covid-19 under control a few months ago, at least compared to the United States. What happened? The countries’ vaccination rates offer an explanation. Europe ...
Blog
Here They Go Again: The Democratic Obsession with Drug Price Controls Will Harm Patients and Diminish Innovation
The U.S. House of Representatives is once again considering “The Lower Drug Costs Now Act”. It was a bad idea in the last Congress, and it is still bad policy today. If it becomes law, this Act (H.R. 3) empowers the federal government to negotiate prices on select drugs for ...
Commentary
What Health-Care Affordability Crisis?
Some 46 million Americans wouldn’t be able to pay for essential health care if they needed it today, according to a new Gallup poll. That’s nearly one-fifth of all adults. This finding suggests a full-on health-care affordability crisis. Or it would, if the numbers added up. But they don’t. A ...
Blog
Winners and Losers – April 23
Tim Anaya – Senior Director of Communications and PRI’s Sacramento Office Winner: CA Businesses Who Received PPP Loans – Businesses in CA that received PPP loans won’t be facing a state tax headache after all, thanks to action this week by the State Senate to allow many small businesses with ...
Commentary
J&J Vaccine ‘Pause’ Reveals U.S. Regulators’ Abundance of Recklessness
It seems obvious that a rapid, widespread vaccination campaign offers our nation the best chance of bringing the COVID-19 pandemic to a swift end. That observation is apparently lost on federal public health officials. Last week, the Centers for Disease and Control and Prevention and the Food and Drug Administration told ...
Blog
Generational Divide: How Divergence Between Millennials vs. Gen Z Should Inform Free Market Messaging
Although millennials and Gen Z’ers diverge in economic, political, and social attitudes, the two are frequently lumped together in discussions regarding the politics of the youth. Understanding the differences can significantly aid free marketers on how to adjust messaging to effectively appeal to each generation. Millennials qualify as individuals born ...
MyTurn Is Actually a Marginal Success Compared to Historic Performance of Government Technology Projects
Reports this week have put MyTurn, California’s $50 million COVID-19 scheduling website, on the long list of IT and technology blunders by government. The headline in the Sacramento Bee says it all, “California spent $50 million for a COVID vaccine scheduling website. It flopped.” The state’s ongoing technological woes should ...
With HR 3, House Democrats Lose Their Grip on Reality
Last week, House Democrats introduced H.R. 3, a bill that would empower the federal government to set prescription drug prices for the entire U.S. pharmaceutical market. The measure comes at the worst possible time. The rapid development of effective vaccines against COVID-19 has demonstrated what can happen when the drug industry ...
Medicare for All Would Put Even More Strain on Doctors
Medicare for All is back on Congress‘s agenda. More than 100 House Democrats, led by Reps. Pramila Jayapal of Washington and Debbie Dingell of Michigan, are behind a bill that would outlaw private insurance and enroll every American in a government-run health plan within two years. They’re joined by a surprisingly large share of ...
Dr. Henry Miller – A COVID-19 Update and Progress on Vaccinations
This week’s guest is Dr. Henry Miller, PRI senior fellow in health care studies. In addition to being a physician, Dr. Miller was a former official at the FDA and founding director of the FDA’s Office of Biotechnology. Dr. Miller provides an update on the pandemic, the progress of vaccine ...
Europe Negotiates A Poor Vaccine Rollout
Several European countries just instituted another round of lockdowns amid a new wave of Covid-19 cases. This turn of events is sobering but puzzling. Europe seemed to have Covid-19 under control a few months ago, at least compared to the United States. What happened? The countries’ vaccination rates offer an explanation. Europe ...
Here They Go Again: The Democratic Obsession with Drug Price Controls Will Harm Patients and Diminish Innovation
The U.S. House of Representatives is once again considering “The Lower Drug Costs Now Act”. It was a bad idea in the last Congress, and it is still bad policy today. If it becomes law, this Act (H.R. 3) empowers the federal government to negotiate prices on select drugs for ...
What Health-Care Affordability Crisis?
Some 46 million Americans wouldn’t be able to pay for essential health care if they needed it today, according to a new Gallup poll. That’s nearly one-fifth of all adults. This finding suggests a full-on health-care affordability crisis. Or it would, if the numbers added up. But they don’t. A ...
Winners and Losers – April 23
Tim Anaya – Senior Director of Communications and PRI’s Sacramento Office Winner: CA Businesses Who Received PPP Loans – Businesses in CA that received PPP loans won’t be facing a state tax headache after all, thanks to action this week by the State Senate to allow many small businesses with ...
J&J Vaccine ‘Pause’ Reveals U.S. Regulators’ Abundance of Recklessness
It seems obvious that a rapid, widespread vaccination campaign offers our nation the best chance of bringing the COVID-19 pandemic to a swift end. That observation is apparently lost on federal public health officials. Last week, the Centers for Disease and Control and Prevention and the Food and Drug Administration told ...
Generational Divide: How Divergence Between Millennials vs. Gen Z Should Inform Free Market Messaging
Although millennials and Gen Z’ers diverge in economic, political, and social attitudes, the two are frequently lumped together in discussions regarding the politics of the youth. Understanding the differences can significantly aid free marketers on how to adjust messaging to effectively appeal to each generation. Millennials qualify as individuals born ...
